Ketorolac intermediates, impurities and metabolites | | | |
2-(5-bromo-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethanol | | 1897489-56-3 | |
2-chloro-4-((4S,5S)-4-((R)-2,2,2-trifluoro-1-hydroxyethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile | | 1371608-50-2 | C14H12ClF3N2O3 |
Clopidogrel impurities and intermediates | | | |
Phosphonium, [3-[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxo-1,6-heptadien-1-yl]-2-methoxyphenoxy]propyl]triphenyl- (ACI) | | 1638920-66-7 | C42H40O6P |
1',4'-cis ABA Diol | | | |
(S)-3'-Iodoabscisic acid | | | |
(S)-3'-Fluoroabscisic acid | | | |
(11E)-11-[3-(Dimethyl amino)propylidene]-6,11- dihydrodibenz[b,e]oxepin-2-acetic Acid Hydrochloride | | | |
2-chloro-4-((4S,5S)-4-((S)-2,2,2-trifluoro-1-hydroxyethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile | | 1371608-49-9 | C14H12ClF3N2O3 |
(S)-3'-Bromoabscisic acid | | | |
Ribociclib impurity-2 (N-Boc Ribociclib) | | | |
Phosphonium, 1,1-[[(1E,6E)-3,5-dioxo-1,6-heptadiene-1,7-diyl]bis[(2-methoxy-4,1-phenylene)oxy-3,1-propanediyl]]bis[1,1,1-triphenyl- (ACI) | | 1638920-65-6 | C63H60O6P2 |
(3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1- methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H- pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5- dihydroxy-heptanoic Acid | | | |
3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5- dihydroxyheptanoic acid | | | |
(S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3- pyrrolidinyl]-2,2-diphenyl-N-[2-(2,3-dihydrobenzfuran- 5-yl)ethyl]acetamide hydrobromide | | | |
(2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2- en-4-yn-1-amin | | | |
sodium 2-((4-((7-Chloroquinolin-4- yl)amino)pentyl)(ethyl)amino)ethyl sulfate | | | |
(S)-3'-chloroabscisic acid | | | |
O-benzylhydroxylamine hydrobromide | | 123850-11-3 | |
1-(2-((2,4-dimethylphenyl)sulfinyl)phenyl)-4-nitrosopiperazine | | | |
2-((4,6-Dichloropyrimidin-2-yloxy)methyl)benzonitrile | | | |
Cyclopentyl (3-(4-carbamoyl-2-methoxybenzyl)-1- methyl-1H-indol-5-yl)carbamate | | | |